From Mild to Mortal
An expert panel dscuss some of the latest research into human genetics, immunology and COVID-19.
Covid Connections – Variant or Villain
The second COVID connections talk brought together experts from COG-UK to discuss SARS-CoV-2 variants.
Genomics in a pandemic – Shedding light on the invisible
Experts from the COVID-19 Genomics UK Consortium discuss sequencing SARS-CoV-2, variants, and viral fitness landscapes.
Car manufacturing, cellular biology and COVID
Rachel Nelson, head of the Cellular Generation and Phenotyping (CGaP) facility, reflects on managing science at scale, including the lessons from industries as far apart as car manufacturing and Silicon Valley.
Championing Team Science
Professor Muzlifah Haniffa shares her thoughts achieving large-scale science.
Fighting Pathogens with Data and Partnerships
"Data analysis in genomics means that you can work in something that is meaningful."
20 Things We Learned in 2020
This has been a year that none of us will forget in a hurry. The Institute is immensely proud of the way our staff have pulled together, and the work we have managed to achieve
Sequencing COVID – what now?
Helping to track coronavirus outbreaks.
The race to sequence SARS-CoV-2
The Sanger Institute is built for high-throughput science – but the project to sequence coronavirus demanded more samples were handled more quickly than ever before.
